Skip Navigation
Skip to contents




10 results

Low Bone Mass Related with Helicobacter pylori Infection in a Woman

Kong EH, Lee JY, Joo IW, Kim HY, Jung MH, Choi H

  • J Korean Soc Osteoporos.
  • 2010 Apr;8(1):82-87.
A 39-year-old female had intermittent dyspepsia for 1 year. She was not a current smoker or an alcohol abuser. An upper gastrointestinal endoscopy showed erosive gastritis; the histologic diagnosis of...
Bisphosphonate-Related Osteonecrosis of the Jaw: Clinical Characteristics of Patients in Korea

Chung YS, Kim EK, Lee MS, Lee JK, Kwon YD, Park YD, Kim DY

  • J Korean Soc Osteoporos.
  • 2010 Apr;8(1):73-81.
OBJECTIVES: The purpose of this study is to describe the clinical characteristics of patients diagnosed with bisphosphonate-related osteonecrosis of the jaw (BRONJ) and to identify potential risk factors. METHODS: Twenty cases...
Effect of Human Growth Hormone to Antioxidant Enzymes in Rat Erythrocyte

Shin CW, Kim SA, Jung H

  • J Korean Soc Osteoporos.
  • 2010 Apr;8(1):64-72.
OBJECTIVES: To observe whether any relationship exists between the dosage of growth hormone and the plasma concentration of malondialdehyde (MDA) or whether a relationship exists between the dosage of growth...
Bone Mineral Density and Bone Turnover Markers after One-year Teriparatide Treatment in Korean Postmenopausal Women with Osteoporosis

Park SY, Bae JH, Kim JY, Oh HJ, Joo IW

  • J Korean Soc Osteoporos.
  • 2010 Apr;8(1):56-63.
OBJECTIVES: Recombinant teriparatide, a bone anabolic agent, is known to result in a net positive bone balance and reduce vertebral and nonvertebral fracture incidence. The objective of this study was...
Differential Expression of RANKL and OPG by the PPAR gamma Agonist Rosiglitazone in Osteoblasts

Lee MJ, Lee SY, Park SH, Ahn DW

  • J Korean Soc Osteoporos.
  • 2010 Apr;8(1):47-55.
OBJECTIVES: Osteoblasts secrete receptor activator of nuclear factor-kB ligand (RANKL) and osteoprotegerin (OPG). RANKL stimulates osteoclastogenesis but OPG inhibits it by binding with RANKL. Although peroxisome proliferation-activated receptor gamma (PPARgamma)...
Amenorrhea and Bone Mineral Density in Premenopausal Women

Kim SR, Kang BM, Jeon GH, Kim SH, Chae HD, Kim CH

  • J Korean Soc Osteoporos.
  • 2010 Apr;8(1):38-46.
OBJECTIVES: This study was designed to investigate the prevalence of low bone mass and to evaluate the influence of amenorrhea on bone mineral density (BMD) in premenopausal women. METHODS: One hundred...
Effects of Combined Estrogen and Effervescent Fluocalcic Therapy on the Bone Mineral Density and Bone Metabolism of Surgical Menopause Women with Osteopenia

Choi H, Jung MH, Joo IW, Kong EH, Lee JY, Kim HY

  • J Korean Soc Osteoporos.
  • 2010 Apr;8(1):26-37.
OBJECTIVE: To evaluate the effects of estrogen therapy and fluocalcic on the bone mineral density and bone metabolism in surgically menopausal osteopenic women. METHODS: This prospective randomized clinical trial examined the...
Osteoporosis and Fracture among Patients with Type 1 and Type 2 Diabetes

Park EJ, Hong SY

  • J Korean Soc Osteoporos.
  • 2010 Apr;8(1):15-25.
Diabetes mellitus is a major risk factor for osteoporotic fractures. The occurrence of Osteoporosis among patients who have diabetes mellitus further increases both economically and physically their burden of disease....
The Situation of Osteoporosis in Thailand: Update for 2010

Limpaphayom KK, Yuktanandana P

  • J Korean Soc Osteoporos.
  • 2010 Apr;8(1):9-14.
Osteoporosis has significant mortality and morbidity which can significantly impact resources. Osteoporosis is not among the top ten health priorities of the Thai government, even though the number of deaths...
Osteopenia: When, How Long and Whom to Treat?

Singh M

  • J Korean Soc Osteoporos.
  • 2010 Apr;8(1):1-8.
Osteopenia or low bone mass is defined as T-Score between -1 and -2.5. The clinical translation of Osteopenia is two fold increase in fracture risk. Osteopenia along with other clinical...

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: